Life Saving Drugs Program – HT1 – Review summary and Expert Panel recommendations
About this resource
Publication date:
Publication type:
Report
Language:
English
Part of a collection:
Australian Government Department of Health, Disability and Ageing
Life Saving Drugs Program – HT1 – Review summary and Expert Panel recommendations
This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.